HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nonalcoholic fatty liver disease (NAFLD) - a new factor that interplays between inflammation, malnutrition, and atherosclerosis in elderly hemodialysis patients.

AbstractBACKGROUND/AIM:
In the past decade, in most regions of the world, an increasing number of adults aged 65 years and older were started on renal replacement therapy each year. In contrast to the general population for whom overnutrition or obesity is associated with increased cardiovascular risk, for patients who are maintained on hemodialysis (HD), malnutrition and malnutrition-inflammation complex syndrome are associated with poor outcome. In recent years, nonalcoholic fatty liver disease (NAFLD) has been considered to be the liver manifestation of metabolic syndrome, and the development of NAFLD is strongly associated with all components of metabolic syndrome (arterial hypertension, dyslipidemia, obesity, and diabetes mellitus type 2) in the general population. The primary end point of this study was to determine the patient's survival in relation to nutritional and inflammatory state and the presence or absence of NAFLD. The secondary end point of this analysis was the association among NAFLD and various clinical and laboratory data, with the nutritional and inflammatory state of our elderly HD patients.
METHODS:
Using a single-center, prospective, cohort study design, we followed the progress of 76 patients who were ≥ 65 years and treated with chronic HD for at least 6 months, at the Department of Nephrology, Dialysis and Transplantation. All patients were followed for a minimum of 18 months or until death. Survival was defined as the time from study initiation to death (or end of study, if still alive).
RESULTS:
The main findings of our study were a remarkable positive correlation between NAFLD and high-sensitivity C-reactive protein (hs-CRP) (r=0.659; P<0.0001) and consequent negative correlation with the nutritional parameter, serum albumin (r=-0.321; P=0.004). Interestingly, we showed that in contrast to the general population, where NAFLD is associated with obesity, in the present study, there was no statistically significant association between NAFLD and overnutrition in elderly HD patients. Furthermore, the presence of NAFLD, low serum albumin levels, and high hs-CRP were strong predictors of poor outcome in our elderly HD patients.
CONCLUSION:
Our results indicated that NAFLD probably interplays between inflammation, malnutrition, and atherosclerosis in elderly HD patients. NAFLD could be a new factor that contributes to type 2 malnutrition in elderly HD patients, who may be amenable to adequate nutritional and HD support.
AuthorsIvana Mikolasevic, Vesna Lukenda, Sanjin Racki, Sandra Milic, Branka Sladoje-Martinovic, Lidija Orlic
JournalClinical interventions in aging (Clin Interv Aging) Vol. 9 Pg. 1295-303 ( 2014) ISSN: 1178-1998 [Electronic] New Zealand
PMID25143715 (Publication Type: Journal Article)
Chemical References
  • Serum Albumin
  • C-Reactive Protein
Topics
  • Aged
  • Aged, 80 and over
  • Atherosclerosis (etiology)
  • C-Reactive Protein (analysis)
  • Croatia
  • Endpoint Determination
  • Female
  • Humans
  • Inflammation (etiology)
  • Kidney Failure, Chronic (etiology, therapy)
  • Male
  • Malnutrition (etiology)
  • Non-alcoholic Fatty Liver Disease (complications)
  • Prospective Studies
  • Renal Dialysis
  • Risk Factors
  • Serum Albumin (analysis)
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: